KMID : 0882420070730001076
|
|
Korean Journal of Medicine 2007 Volume.73 No. 0 p.1076 ~ p.1080
|
|
A case of systemic sclerosis with good response to rituximab
|
|
Pack Yun-Jung
Lee Su-Yeon Cho Jae-Hyoung Oh Seung-Hyun Lee Joo-Ha Kim Hyun-Sook Kim Wan-Uk
|
|
Abstract
|
|
|
Systemic sclerosis (SSc) is a connective tissue disease characterized by tissue fibrosis. Classically the pathogenesis of SSc involves three main disease processes including mainly T-cell mediated upregulated autoimmunity, excess fibrosis due to increased fibroblast activity and proliferative obliterating vasculopathy. However, recent studies suggest that SSc patients have intrinsic B cell abnormalities characterized by decreased but activated memory B cells. Augmented cytokine production, by B cells, is a potential candidate for the induction of skin sclerosis. In addition, B cells may influence tissue fibrosis by regulating T cell activation and cytokine production through their antigen-presenting and co-stimulatory activities. Current data obtained from studies on B-cell ablation therapy using rituximab for autoimmune diseases show good tolerability and sustained improvement in disease symptoms. We treated a patient with refractory SSc who showed improvement of the skin sclerosis after rituximab therapy.(Korean J Med 73:S1076-S1080, 2007)
|
|
KEYWORD
|
|
Systemic sclerosis, Rituximab
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|